Avid Bioservices Quote - CDMOP

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

25.06

Bid

18.00

Ask

26.00

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

1.591B

Previous Close

25.06

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

63,480,000

Dividend Yield

PE Ratio

-5.56

Earnings Per Share (EPS)

-2.22

Revenue

139.91M

Net Profit

-140.75M

Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development and high-quality CGMP cli... Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development and high-quality CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.peregrineinc.com

Headquarters

Wilmington, Delaware, USA

Founded

Avid Bioservices Recommends Stockholders Vote FOR Value Maximizing Transaction

TUSTIN, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization...

Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2024

TUSTIN, Calif., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve...

Avid Bioservices to be Acquired by GHO Capital Partners and Ampersand Capital Partners in $1.1 Billion Transaction

TUSTIN, Calif. and LONDON and BOSTON, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and...

Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference

TUSTIN, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve...

Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024

-- Recorded First Quarter Revenue of $40.2 Million -- -- Signed $66 Million in Net New Business, Resulting in Backlog of $219 Million -- -- Maintained FY2025 Revenue Guidance of Between $160...

Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024

TUSTIN, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve...

Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024

-- Recorded Fourth Quarter Revenue of $43.0 Million – Highest in Company History -- -- Signed $30 Million in Net New Business Resulting in Backlog of $193 Million -- -- New Mammalian and Cell...

Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024

TUSTIN, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve...

Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance

TUSTIN, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve...

Avid Bioservices to Participate at Upcoming Investor Conferences

TUSTIN, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	PR
4	0	0	0	0	0	0	0	PR
12	0	0	0	0	0	0	0	PR
26	0	0	0	0	0	0	0	PR
52	0	0	0	0	0	0	0	PR
156	0	0	0	0	0	0	0	PR
260	0	0	0	0	0	0	0	PR

CDMOP - Frequently Asked Questions (FAQ)

What is the current Avid Bioservices share price?

The current share price of Avid Bioservices is US$ 25.06

How many Avid Bioservices shares are in issue?

Avid Bioservices has 63,480,000 shares in issue

What is the market cap of Avid Bioservices?

The market capitalisation of Avid Bioservices is USD 1.59B

What is the 1 year trading range for Avid Bioservices share price?

Avid Bioservices has traded in the range of US$ 0.00 to US$ 0.00 during the past year

What is the PE ratio of Avid Bioservices?

The price to earnings ratio of Avid Bioservices is -5.56

What is the cash to sales ratio of Avid Bioservices?

The cash to sales ratio of Avid Bioservices is 5.59

What is the reporting currency for Avid Bioservices?

Avid Bioservices reports financial results in USD

What is the latest annual turnover for Avid Bioservices?

The latest annual turnover of Avid Bioservices is USD 139.91M

What is the latest annual profit for Avid Bioservices?

The latest annual profit of Avid Bioservices is USD -140.75M

What is the registered address of Avid Bioservices?

The registered address for Avid Bioservices is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Avid Bioservices website address?

The website address for Avid Bioservices is www.peregrineinc.com

Which industry sector does Avid Bioservices operate in?

Avid Bioservices operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MYSZMy Size Inc	US$ 4.2001 (211.12%)	121.03M
NVNINVNI Group Ltd	US$ 8.26 (209.36%)	78.06M
TPICTPI Composites Inc	US$ 2.45 (100.82%)	34M
ICGIntchains Group Ltd	US$ 8.77 (88.60%)	527.94k
HSDTHelius Medical Technologies Inc	US$ 0.884851 (84.34%)	121.95M
CYNCYNGN Inc	US$ 0.4603 (-71.41%)	27.5M
MTEMMolecular Templates Inc	US$ 0.1502 (-57.09%)	8.63M
PRFXPainReform Ltd	US$ 5.15 (-53.85%)	2.84M
GALTGalectin Therapeutics Inc	US$ 1.03 (-48.50%)	8.58M
BCABBioAtla Inc	US$ 0.6923 (-41.82%)	5.96M
EDBLEdible Garden AG Inc	US$ 0.24 (65.06%)	354.32M
APTOAptose Biosciences Inc	US$ 0.28 (64.51%)	305.1M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.606999 (6.49%)	292.16M
NVDANVIDIA Corporation	US$ 134.70 (3.08%)	287.21M
PLTRPalantir Technologies Inc	US$ 80.55 (8.54%)	277.63M